Daily versus standard hemodialysis: one year experience

Area of Science:

• Nephrology
• Cardiology
• Clinical Nutrition

Background:

• Hypertension and left ventricular hypertrophy are common complications in uremic patients undergoing hemodialysis.
• Standard hemodialysis regimens may not fully address these comorbidities.
• Optimizing dialysis frequency could offer clinical benefits.

Purpose of the Study:

• To compare clinical and biological outcomes in hemodialysis patients before and after conversion to daily hemodialysis.
• To evaluate the impact of increased dialysis frequency on cardiovascular parameters and nutritional status.

Main Methods:

• A cohort of 4 hemodialysis patients was switched from thrice-weekly sessions (4-5 hours each) to daily sessions (2-2.5 hours each).
• Total weekly dialysis time and modalities remained constant.
• Clinical and biochemical parameters, including blood pressure, left ventricular mass index, urea time averaged deviation (TAD), Kt/V, caloric intake, and normalized protein catabolic rate (nPCR), were monitored.

Main Results:

• Daily hemodialysis led to significant reductions in blood pressure (p < 0.01) and left ventricular mass index (p < 0.01).
• Improvements were observed in urea TAD (p < 0.005) and Kt/V (p < 0.05).
• Patients showed increased caloric intake (p < 0.05) and nPCR (p < 0.0038), with one patient discontinuing erythropoietin therapy.

Conclusions:

• Daily hemodialysis appears to be a superior treatment strategy for managing hypertension and left ventricular hypertrophy in uremic patients.
• The increased frequency of dialysis, leading to improved urea clearance, likely explains the observed clinical improvements.
• Daily hemodialysis positively impacts cardiovascular health and nutritional status in hemodialyzed individuals.